Search
for

    Sort by

    Research 901–930 of 1000+

    1. Does a male polycystic ovarian syndrome equivalent exist? Journal of Endocrinological Investigation · 2017 · 28 citations
    2. Androgenetic alopecia as an early marker of benign prostatic hyperplasia Journal of The American Academy of Dermatology · 2011 · 28 citations
    3. Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids Endocrine, metabolic & immune disorders. Drug targets · 2006 · 26 citations
    4. Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease Endocrine Related Cancer · 2019 · 25 citations
    5. Testosterone therapy in men: Clinical and pharmacological perspectives Journal of Endocrinological Investigation · 2000 · 25 citations
    6. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations
    7. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    8. Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male Journal of the American Geriatrics Society · 1984 · 23 citations
    9. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    10. Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry 2017 · 22 citations
    11. Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors Journal of Medicinal Chemistry · 2002 · 22 citations
    12. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations
    13. Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i> Chemistry & Biodiversity · 2009 · 20 citations
    14. Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · 2007 · 20 citations
    15. Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors Current Medicinal Chemistry · 2005 · 20 citations
    16. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    17. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians Asian journal of urology · 2017 · 19 citations
    18. Synthesis and structure–activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands Bioorganic & Medicinal Chemistry Letters · 2001 · 18 citations
    19. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study Archives of Cardiovascular Diseases · 2019 · 17 citations
    20. The Influence of Age-Related Cues on Health and Longevity Perspectives on Psychological Science · 2010 · 17 citations
    21. Safety aspects of androgen treatment with 5α-dihydrotestosterone Andrologia · 2007 · 16 citations
    22. Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: Relation of their systemic activity to the formation of a common metabolite The Journal of Steroid Biochemistry and Molecular Biology · 1994 · 16 citations
    23. The Effect of Anti-Androgens on the Response of Rat Preputial Glands to Testosterone* 1964 · 16 citations
    24. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    25. Development of finasteride/PHBV@polyvinyl alcohol/chitosan reservoir-type microspheres as a potential embolic agent: from <i>in vitro</i> evaluation to animal study Biomaterials Science · 2020 · 14 citations
    26. Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogens European journal of medicinal chemistry · 2014 · 14 citations
    27. Finasteride for prostatic disease: an updated and comprehensive review Expert opinion on drug metabolism & toxicology · 2008 · 14 citations
    28. New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide) Steroids · 2005 · 14 citations
    29. Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura Actas Urológicas Españolas · 2003 · 14 citations
    30. Practical Geriatrics: Men's Sexual Health After Midlife Psychiatric Services · 2001 · 14 citations